Tris Pharma Inc.

Form 483 issued June 8, 2021 · Monmouth Junction, New Jersey

Inspection
May 3 – Jun 8, 2021
Observations
7
Pages
19
FEI number
3004712471

In short: On June 8, 2021, FDA issued a Form 483 with 7 observations to Tris Pharma Inc. in Monmouth Junction, New Jersey (FEI 3004712471) after an inspection that ran May 3 – Jun 8, 2021. The investigators were Jay B. Shah and Rose Jean-Mary. Most observations concern facilities & equipment and quality system.

At a glance

Facilities & equipment and quality system account for 5 of 7 observations.

Facilities & equipment3
Quality system2
Production1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit are not in…

  2. 02

    Protective apparel is not worn as necessary to protect…

  3. 03

    Investigations of an unexplained discrepancy and a failure of a batch or any of its components…

  4. 04

    An NDA-Field Alert Report was not submitted within three working days of receipt of information concerning…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Tris Pharma Inc.?

FDA listed 7 observations on this Form 483, mostly about facilities & equipment, quality system and production. The opening words of each observation are shown on this page.

Who inspected Tris Pharma Inc.?

Jay B. Shah and Rose Jean-Mary are named on this Form 483, for the inspection of May 3 – Jun 8, 2021. Each investigator has a profile showing what they cite most.

When was Tris Pharma Inc. inspected by FDA?

The inspection ran May 3 – Jun 8, 2021, and the Form 483 is dated June 8, 2021.

How do I get the full Form 483 for Tris Pharma Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free